Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elisabetta Verdun di Cantogno"'
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Introduction: Pregnancy is widely accepted as a period when relapses of multiple sclerosis (MS) are decreased, with an increased risk of relapse in the first months postpartum. This systematic review evaluated relapses during pregnancy and postpartum
Externí odkaz:
https://doaj.org/article/b7d6f9d4b983426f9486c0cb22ee7040
Autor:
María Isabel Zuluaga Rodas, Laura Negrotto, Mariana Deramo, Jihad Inshasi, Amir Boshra, Joseph Youssef, Sabrina De Souza, Elisabetta Verdun Di Cantogno, Tahani Boumenna
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104351
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b5ad42ee5d771f43c99ad9fbed7633b
https://doi.org/10.1016/j.msard.2022.104351
https://doi.org/10.1016/j.msard.2022.104351
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::578678aa74e06ed325e2e183ab784e02
https://doi.org/10.1016/j.msard.2022.104287
https://doi.org/10.1016/j.msard.2022.104287
Autor:
Jiwon Oh, Mavis Ayer, Raed Alroughani, Caroline Lemieux, Kate Morgan, Mariana D'eramo, Tiffany Vella, Amir Boshra, Sabrina De Souza, Elisabetta Verdun Di Cantogno, Meritxell Sabido Espin
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74b58819d54a746607de9132f6afb0dc
https://doi.org/10.1016/j.msard.2022.104288
https://doi.org/10.1016/j.msard.2022.104288
Publikováno v:
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Introduction: Pregnancy is widely accepted as a period when relapses of multiple sclerosis (MS) are decreased, with an increased risk of relapse in the first months postpartum. This systematic review evaluated relapses during pregnancy and postpartum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af72822ae306bd3fb354cf74ae26903b
http://europepmc.org/articles/PMC8645312
http://europepmc.org/articles/PMC8645312
Publikováno v:
Multiple Sclerosis and Related Disorders. 59:103633
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef616eede6f1794c727bfa5984c8e187
https://doi.org/10.1016/j.msard.2022.103633
https://doi.org/10.1016/j.msard.2022.103633
Autor:
David Leppert, Olga Ciccarelli, Maria Pia Sormani, Claudia A. M. Wheeler-Kingshott, Davorka Tomic, Elisabetta Verdun di Cantogno, David Baker, Gavin Giovannoni, David L. Selwood, Robert Hyde, Paul M. Matthews, Klaus Schmierer, Shibeshih Belachew, Daniele Carassiti, Gary Cutter, Robert M. Herndon, Ali-Frederic Ben-Amor, Harold Koendgen, Volker Knappertz
Publikováno v:
Multiple Sclerosis and Related Disorders. 12:70-78
Trials of anti-inflammatory therapies in non-relapsing progressive multiple sclerosis (MS) have been stubbornly negative except recently for an anti-CD20 therapy in primary progressive MS and a S1P modulator siponimod in secondary progressive MS. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5fd9015736606fcd2eb7970e064ad1d
https://doi.org/10.1016/j.msard.2017.01.007
https://doi.org/10.1016/j.msard.2017.01.007
Autor:
Jürg Kesselring, Elisabetta Verdun di Cantogno, Sven Schippling, Patrick Vermersch, Peter Rieckmann
Publikováno v:
Multiple Sclerosis and Related Disorders. 26:252-253
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdb9f56ef26bc3e572c67a793f89595f
https://doi.org/10.1016/j.msard.2018.10.073
https://doi.org/10.1016/j.msard.2018.10.073
Autor:
Peter Cornelisseª, Ludwig Kappos, Magnhild Sandberg-Wollheim, Bernard M. J. Uitdehaag, David Kb Li, Elisabetta Verdun di Cantogno, Anthony Traboulsee, Peter Joseph Jongen, Cris S. Constantinescu
Publikováno v:
Multiple sclerosis journal-experimental, translational and clinical
Objective The objective of this article is to investigate potential clinical and MRI predictors of long-term outcomes in multiple sclerosis (MS). Methods This was a post hoc analysis using data from all 382 patients in the PRISMS long-term follow-up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6295f4bcaa3e68b3477a0cced0d42c2
http://europepmc.org/articles/PMC5433509
http://europepmc.org/articles/PMC5433509
Publikováno v:
Therapeutic Delivery. 2:1455-1465
Multiple sclerosis is a chronic disease requiring lifelong treatment with disease-modifying drugs that aim to prevent relapses and slow the progression of disability. The established first-line treatments for multiple sclerosis all require regular in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa48cbe3594cb99dab63e5b69f8ee66
https://doi.org/10.4155/tde.11.116
https://doi.org/10.4155/tde.11.116